Cognitive Recovery Following Immune Effector Cell-Associated Neurotoxicity Syndrome in the First 6 Months after Chimeric Antigen Receptor T-Cell Therapy
Open Access
- 25 March 2026
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 32 (7) , 860.e1-860.e12
Abstract
No abstract availableKeywords
Funding Information
- Department of Education, Australian Government
This publication has 27 references indexed in Scilit:
- Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in MyelomaTransplantation and Cellular Therapy, 2024
- Real-World Outcomes with Chimeric Antigen Receptor T Cell Therapies in Large B Cell Lymphoma: A Systematic Review and Meta-AnalysisTransplantation and Cellular Therapy, 2023
- Cognition following chimeric antigen receptor T-cell therapy: A systematic reviewJournal of Autoimmunity, 2023
- Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for LymphomaTransplantation and Cellular Therapy, 2022
- Change in Neurocognitive Performance Among Patients with Non-Hodgkin Lymphoma in the First Year after Chimeric Antigen Receptor T Cell TherapyTransplantation and Cellular Therapy, 2022
- Clinical Presentation, Risk Factors, and Outcomes of Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T Cell Therapy: A Systematic ReviewTransplantation and Cellular Therapy, 2022
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector CellsTransplantation and Cellular Therapy, 2019
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Trail Making Test A and B: Normative data stratified by age and educationArchives of Clinical Neuropsychology, 2004